Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

January 5, 2024

https://www.globenewswire.com/news-release/2024/01/05/2804872/0/en/Senti-Bio-Announces-Strategic-Steps-to-Prioritize-Investment-in-Lead-Clinical-Program.html

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1 clinical trial of SENTI-202 expected in 2H 2024 –

Read more at globenewswire.com

Related news for (SNTI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.